KENDALL WELLS: Open Payments
NPI 1831977461 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 56 payments from 17 companies in 2025. Trend: 2023 $282 · 2024 $2,299 · 2025 $1,221
Food & beverage: $1,221
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 17 | $236 |
| Organon LLC | 5 | $147 |
| Novartis Pharmaceuticals Corporation | 4 | $137 |
| UCB, Inc. | 1 | $104 |
| LEO Pharma Inc. | 4 | $78 |
| Lilly USA, LLC | 3 | $76 |
| Amgen Inc. | 3 | $74 |
| ABBVIE INC. | 3 | $70 |
| Incyte Corporation | 3 | $58 |
| Galderma Laboratories, L.P. | 3 | $51 |
Products named: Zoryve, VTAMA, Bimzelx, COSENTYX, EBGLYSS, OTEZLA, ADBRY, OPZELURA.
Industry payments across FL — which companies pay providers there.
